News
Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...
In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its ...
The healthcare industry offers many attractive dividend investments. Both Johnson & Johnson as well as Pfizer have a positive outlook.
The CDC has approved eligibility guidelines for the Pfizer vaccine booster. Recommendations for Moderna and Johnson & Johnson could come soon.
Comparing the COVID-19 vaccines: If you have a choice, which one should you get? Pfizer, Moderna and Johnson & Johnson are all safe and effective, but there are some differences.
Health experts say not to hold out for a certain vaccine. But Pfizer, Moderna and Johnson & Johnson doses are available in Illinois. Can you choose?
Soon we will be turning another page in the pandemic playbook: A third vaccine, this one from Johnson & Johnson, looks headed to market by early March, joining vaccines from Pfizer and Moderna ...
Pfizer's and Moderna's COVID-19 vaccines were near perfect at preventing symptomatic infections in trials. Johnson & Johnson's shot has benefits: It's cheap, easy, and mild, and it performs ...
According to medical experts, the Johnson & Johnson, Pfizer and Moderna COVID vaccines each offer some level of protection, but how do they compare to each ...
CDC recommends Pfizer, Moderna vaccines over Johnson & Johnson, citing rare blood-clot issue Nine deaths, several dozen cases, have been confirmed in connection with the vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback